Majem, Margarita, Rosa Álvarez, Ana Laura Ortega, Lucía Ruiz de Alda, Rocío Gordo, J Francisco García, Yoana Ivanova-Markova, Almudena González-Domínguez, Raquel Sánchez San Cristóbal, and Federico Rojo. “Cost-Benefit Analysis of ALK Diagnosis Vs. Non-Diagnosis in Patients With Advanced non–small Cell Lung Cancer in Spain”. Global and Regional Health Technology Assessment 9, no. 1 (September 12, 2022): 82–90. Accessed April 24, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/2449.